MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
77 hedge funds and large institutions have $26.9M invested in Melinta Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
50% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 28
82% less capital invested
Capital invested by funds: $149M → $26.9M (-$123M)
Holders
77
Holding in Top 10
1
Calls
$19K
Puts
$12K
Top Buyers
| 1 | +$761K | |
| 2 | +$533K | |
| 3 | +$449K | |
| 4 |
Two Sigma Investments
New York
|
+$203K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$141K |
Top Sellers
| 1 | -$7.74M | |
| 2 | -$1.57M | |
| 3 | -$1.22M | |
| 4 |
FTIOP
Fiduciary Trust International of Pennsylvania
Radnor,
Pennsylvania
|
-$1.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$840K |